Pharma & Biotech

The biopharmaceutical firm Exelixis is generating significant attention with its developmental cancer treatment, Zanzalintinib. While the company already markets CABOMETYX...

Arvinas investors are bracing for what could prove to be the most consequential week of the year for the biotechnology...

Biotechnology firm Denali Therapeutics has encountered a significant regulatory hurdle. The U.S. Food and Drug Administration has postponed its decision...

The equity value of Anika Therapeutics is caught in a pronounced downward trend. Following a substantial price decline on Friday,...

Seres Therapeutics finds itself at a critical crossroads, implementing severe workforce reductions while simultaneously advancing a promising clinical program. The...

Swiss biopharmaceutical firm Idorsia Ltd has successfully completed a significantly oversubscribed capital raise, generating CHF 65.6 million. The company placed...

Moderna, the pioneering vaccine developer, may be on the verge of its most significant achievement since its COVID-19 vaccine success....

A substantial $2.7 billion charge has delivered a significant blow to biotechnology leader AbbVie, forcing the company to dramatically lower...

A potentially transformative moment for NuCana shareholders arrives today as the European Society for Medical Oncology (ESMO) prepares to disclose...

Pharmaceutical leader Eli Lilly is making decisive moves to position itself for its next growth chapter, combining a strategic executive...